N
N. Viget
Publications - 43
Citations - 2312
N. Viget is an academic researcher. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 15, co-authored 38 publications receiving 1971 citations.
Papers
More filters
Journal ArticleDOI
European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.
Jean-François Rahier,Fernando Magro,Candida Abreu,Alessandro Armuzzi,Shomron Ben-Horin,Yehuda Chowers,Mario Cottone,L. de Ridder,Glen A. Doherty,Robert Ehehalt,Maria Esteve,K.H. Katsanos,Charlie W. Lees,Eithne MacMahon,Tom G. Moreels,Walter Reinisch,Herbert Tilg,Lydjie Tremblay,Gigi Veereman-Wauters,N. Viget,Yazdan Yazdanpanah,Rami Eliakim,Jean-Frederic Colombel +22 more
TL;DR: The treatment of inflammatory bowel disease has been revolutionised over the past decade by the increasing use of immunomodulators, mainly azathioprine/6-mercaptopurine and methotrexate, together with the advent of biological therapy.
Journal ArticleDOI
Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis
N. Viget,Gwenola Vernier-Massouille,Dominique Salmon-Céron,Yazdan Yazdanpanah,Jean-Frederic Colombel +4 more
TL;DR: The preventive measures that would help to reduce the rate of opportunistic infections in patients with IBD are listed, and the management of situations frequently confronting doctors is considered.
Journal ArticleDOI
ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease.
Torsten Kucharzik,Pierre Ellul,T Greuter,J F Rahier,Bram Verstockt,Candida Abreu,Andreia Albuquerque,Mariangela Allocca,Maria Esteve,Francis A Farraye,Hannah Gordon,Konstantinos Karmiris,Uri Kopylov,Julien Kirchgesner,Eithne MacMahon,Fernando Magro,Christian Maaser,L. de Ridder,Carlos Taxonera,M Toruner,Lydjie Tremblay,Michael Scharl,N. Viget,Yamile Zabana,Stephan R. Vavricka +24 more
Journal ArticleDOI
High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugs
Clotilde Allavena,Cyrille Delpierre,Lise Cuzin,David Rey,N. Viget,J. Bernard,P. Guillot,Claudine Duvivier,Claudine Duvivier,Eric Billaud,François Raffi +10 more
TL;DR: Vitamin D deficiency is frequent in this HIV-infected adult patients followed in five French centres and efavirenz was the only drug to be significantly associated with deficiency, with an aOR of 1.89, while no effect of the other antiretrovirals, including the latest, was found.
Journal ArticleDOI
Inflammatory Bowel Disease Management During the COVID-19 Outbreak: The Ten Do's and Don'ts from the ECCO-COVID Taskforce.
Fernando Magro,J F Rahier,Cândida Abreu,Eithne MacMahon,Ailsa Hart,C.J. van der Woude,Hannah Gordon,Michel Adamina,N. Viget,Stephan R. Vavricka,Torsten Kucharzik,S. Leone,Britta Siegmund,Silvio Danese,Laurent Peyrin-Biroulet +14 more
TL;DR: The review highlighted that IBD, per se, is not a risk factor for COVID-19 and all IBD patients with symptoms should be tested for SARS-CoV-2 and the procedures for disease management shall be carefully adapted.